Novel SOD1 N86K mutation is associated with a severe phenotype in familial ALS

Muscle and Nerve

Volumn 36, Issue 1, 2007, Pages 111-114

  Beck, Marcus ^a   Sendtner, Michael ^a   Toyka, Klaus V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Mutation; Phenotype; Prognosis; SOD1

Indexed keywords

ADULT; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; DISEASE ACTIVITY; DISEASE COURSE; FAMILIAL DISEASE; FAMILY HISTORY; GENE; GENE MUTATION; HETEROZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; SOD1 GENE;

AMYOTROPHIC LATERAL SCLEROSIS; ASPARAGINE; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYSINE; MIDDLE AGED; MUTATION; PHENOTYPE; SUPEROXIDE DISMUTASE;

EID: 34347354304     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20756     Document Type: Article

References (15)

1. Agar J, Durham H. Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:232-242.
2. Aoki M, Abe K, Houi K, Ogasawara M, Matsubara Y, Kobayashi T, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation. Ann Neurol 1995;37:676-679.
3. Aoki M, Abe K, Itoyama Y. Molecular analysis of the Cu/Zn superoxide dismutase gene in patients with familial amyotrophic lateral sclerosis (ALS) in Japan. Cell Mol Neurobiol 1998;18:639-647.
4. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression in inherited ALS determined by motoneurons and microglia. Science 2006; 312:1389-1392.
5. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-749.
6. Hayward C, Brock DJ, Minns RA, Swingler RJ. Homozygosity for Asn86Ser mutation in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis. J Med Genet 1998;35:174.
7. Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, Stewart C, et al. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 2002;82:365-374.
8. Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology 1997;48:55-57.
9. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25:709-714.
10. Miyazaki K, Fujita T, Ozaki T, Kato C, Kurose Y, Sakamoto M, et al. NEDL1, a novel ubiqutin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J Biol Chem 2004;279:11327-11335.
11. Mochizuki Y, Mizutani T, Nakano R, Fukushima T, Honma T, Nemoto N, et al. Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with an H43R mutation in Cu/Zn superoxide dismutase. Rinsho Shinkeigaku 2003;43:491-495.
12. Shaw PJ. Molecular and cellular pathways of neurodegeneration in motor neuron disease. J Neurol Neurosurg Psychiatry 2005;76:1046-1057.
13. Stieber A, Gonatas JO, Moore JS, Bantly A, Yim HS, Yim MB, et al. Disruption of the structure of the Golgi apparatus and function of the secretory pathway by mutants G93A and G85R of Cu,Zn superoxide dismutase (SOD1) of familial amyotrophic lateral sclerosis. J Neurol Sci 2004;219:45-53.
14. Valentine JS, Hart PJ. Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2003;100:3617-3622.
15. Valentine JS, Doucette PA, Potter SZ. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 2005;74:563-593.